Depletion of 5-HT disrupts prepulse inhibition in rats: Dependence on the magnitude of depletion, and reversal by a 5-HT precursor

Eric P M Prinssen, Marie Bernadette Assié, Wouter Koek, Mark S. Kleven

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The 5-HT1A agonist 8-OH-DPAT has been reported to disrupt prepulse inhibition (PPI) of the acoustic startle reflex after local administration into the raphe nuclei. Because it is likely that 8-OH-DPAT disrupted PPI by activation of somatodendritic inhibitory receptors, and thereby, via a decrease in 5-HT neurotransmission, we tested whether chronic, drug-induced, depletions of 5-HT have similar effects. Rats were drug-treated for three consecutive days and tested in a short PPI paradigm on day 4, and retested 2 h later, after acute saline or drug administration. Repeated treatment with the 5-HT synthesis inhibitor p-chlorophenylalanine methyl ester (PCPA; 160 mg/kg) produced a small, but significant, attenuation of PPI, and a large decrease in extracellular 5-HT levels in the hippocampus, as measured in independent microdialysis experiments. An even larger depletion of 5-HT was obtained by substituting the 3rd PCPA administration with the 5-HT releaser d-fenfluramine (10 mg/kg); this combined treatment nearly abolished PPI in the majority of animals. The involvement of 5-HT in the latter effects was confirmed by the finding that low doses of the 5-HT precursor 5-hydroxy-L-tryptophan reinstated PPI during retest. These data, together with recently published studies, provide strong evidence that pharmacologically-induced depletion of 5-HT disrupts PPI.

Original languageEnglish (US)
Pages (from-to)340-347
Number of pages8
JournalNeuropsychopharmacology
Volume26
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Serotonin
8-Hydroxy-2-(di-n-propylamino)tetralin
Startle Reflex
Pharmaceutical Preparations
Serotonin 5-HT1 Receptor Agonists
Fenfluramine
Prepulse Inhibition
5-Hydroxytryptophan
Raphe Nuclei
Microdialysis
Synaptic Transmission
Tryptophan
Hippocampus
Therapeutics

Keywords

  • 5-hydroxytryptophan
  • d-fenfluramine
  • Microdialysis
  • p-chlorophenylalanine
  • Prepulse inhibition
  • Serotonin
  • Startle reflex

ASJC Scopus subject areas

  • Pharmacology

Cite this

Depletion of 5-HT disrupts prepulse inhibition in rats : Dependence on the magnitude of depletion, and reversal by a 5-HT precursor. / Prinssen, Eric P M; Assié, Marie Bernadette; Koek, Wouter; Kleven, Mark S.

In: Neuropsychopharmacology, Vol. 26, No. 3, 2002, p. 340-347.

Research output: Contribution to journalArticle

@article{d2ce2fe202024a2b84c6dfe5f9fbcb5f,
title = "Depletion of 5-HT disrupts prepulse inhibition in rats: Dependence on the magnitude of depletion, and reversal by a 5-HT precursor",
abstract = "The 5-HT1A agonist 8-OH-DPAT has been reported to disrupt prepulse inhibition (PPI) of the acoustic startle reflex after local administration into the raphe nuclei. Because it is likely that 8-OH-DPAT disrupted PPI by activation of somatodendritic inhibitory receptors, and thereby, via a decrease in 5-HT neurotransmission, we tested whether chronic, drug-induced, depletions of 5-HT have similar effects. Rats were drug-treated for three consecutive days and tested in a short PPI paradigm on day 4, and retested 2 h later, after acute saline or drug administration. Repeated treatment with the 5-HT synthesis inhibitor p-chlorophenylalanine methyl ester (PCPA; 160 mg/kg) produced a small, but significant, attenuation of PPI, and a large decrease in extracellular 5-HT levels in the hippocampus, as measured in independent microdialysis experiments. An even larger depletion of 5-HT was obtained by substituting the 3rd PCPA administration with the 5-HT releaser d-fenfluramine (10 mg/kg); this combined treatment nearly abolished PPI in the majority of animals. The involvement of 5-HT in the latter effects was confirmed by the finding that low doses of the 5-HT precursor 5-hydroxy-L-tryptophan reinstated PPI during retest. These data, together with recently published studies, provide strong evidence that pharmacologically-induced depletion of 5-HT disrupts PPI.",
keywords = "5-hydroxytryptophan, d-fenfluramine, Microdialysis, p-chlorophenylalanine, Prepulse inhibition, Serotonin, Startle reflex",
author = "Prinssen, {Eric P M} and Assi{\'e}, {Marie Bernadette} and Wouter Koek and Kleven, {Mark S.}",
year = "2002",
doi = "10.1016/S0893-133X(01)00348-7",
language = "English (US)",
volume = "26",
pages = "340--347",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Depletion of 5-HT disrupts prepulse inhibition in rats

T2 - Dependence on the magnitude of depletion, and reversal by a 5-HT precursor

AU - Prinssen, Eric P M

AU - Assié, Marie Bernadette

AU - Koek, Wouter

AU - Kleven, Mark S.

PY - 2002

Y1 - 2002

N2 - The 5-HT1A agonist 8-OH-DPAT has been reported to disrupt prepulse inhibition (PPI) of the acoustic startle reflex after local administration into the raphe nuclei. Because it is likely that 8-OH-DPAT disrupted PPI by activation of somatodendritic inhibitory receptors, and thereby, via a decrease in 5-HT neurotransmission, we tested whether chronic, drug-induced, depletions of 5-HT have similar effects. Rats were drug-treated for three consecutive days and tested in a short PPI paradigm on day 4, and retested 2 h later, after acute saline or drug administration. Repeated treatment with the 5-HT synthesis inhibitor p-chlorophenylalanine methyl ester (PCPA; 160 mg/kg) produced a small, but significant, attenuation of PPI, and a large decrease in extracellular 5-HT levels in the hippocampus, as measured in independent microdialysis experiments. An even larger depletion of 5-HT was obtained by substituting the 3rd PCPA administration with the 5-HT releaser d-fenfluramine (10 mg/kg); this combined treatment nearly abolished PPI in the majority of animals. The involvement of 5-HT in the latter effects was confirmed by the finding that low doses of the 5-HT precursor 5-hydroxy-L-tryptophan reinstated PPI during retest. These data, together with recently published studies, provide strong evidence that pharmacologically-induced depletion of 5-HT disrupts PPI.

AB - The 5-HT1A agonist 8-OH-DPAT has been reported to disrupt prepulse inhibition (PPI) of the acoustic startle reflex after local administration into the raphe nuclei. Because it is likely that 8-OH-DPAT disrupted PPI by activation of somatodendritic inhibitory receptors, and thereby, via a decrease in 5-HT neurotransmission, we tested whether chronic, drug-induced, depletions of 5-HT have similar effects. Rats were drug-treated for three consecutive days and tested in a short PPI paradigm on day 4, and retested 2 h later, after acute saline or drug administration. Repeated treatment with the 5-HT synthesis inhibitor p-chlorophenylalanine methyl ester (PCPA; 160 mg/kg) produced a small, but significant, attenuation of PPI, and a large decrease in extracellular 5-HT levels in the hippocampus, as measured in independent microdialysis experiments. An even larger depletion of 5-HT was obtained by substituting the 3rd PCPA administration with the 5-HT releaser d-fenfluramine (10 mg/kg); this combined treatment nearly abolished PPI in the majority of animals. The involvement of 5-HT in the latter effects was confirmed by the finding that low doses of the 5-HT precursor 5-hydroxy-L-tryptophan reinstated PPI during retest. These data, together with recently published studies, provide strong evidence that pharmacologically-induced depletion of 5-HT disrupts PPI.

KW - 5-hydroxytryptophan

KW - d-fenfluramine

KW - Microdialysis

KW - p-chlorophenylalanine

KW - Prepulse inhibition

KW - Serotonin

KW - Startle reflex

UR - http://www.scopus.com/inward/record.url?scp=0036179970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036179970&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(01)00348-7

DO - 10.1016/S0893-133X(01)00348-7

M3 - Article

C2 - 11850148

AN - SCOPUS:0036179970

VL - 26

SP - 340

EP - 347

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 3

ER -